Nizatidine
Product Images NDC 21695-043

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nizatidine (NDC 21695-043). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nizatidine Chemical Structure (487b4138 F7db 480f 96d2 8010fd5c0c06 01)

FDA Label Image

Nizatidine 300mg (487b4138 F7db 480f 96d2 8010fd5c0c06 02)

Nizatidine 300mg (487b4138 F7db 480f 96d2 8010fd5c0c06 02)
This is a description of medication named Nizatidine 300mg which comes in a bottle of 30 capsules. Each capsule contains 300mg of Nizatidine USP and is distributed by Phy. The capsules are light brown and opaque with imprint "W1" and "3138". The product is identified by ID RNOD4330CA and manufactured by Watson Pharma in India. It is a prescription medication and should be kept at a controlled room temperature, away from children. The text includes some unreadable characters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.